LL-D49194beta1
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Antibiotics |
| Catalog number | BBF-03626 |
| CAS | 99743-20-1 |
| Molecular Weight | 1011.02 |
| Molecular Formula | C48H66O23 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
LL-D49194beta1 is produced by the strain of Streptomyces vinaceusdrappus LL-D49194. It has anti-gram-positive bacteria activity and anti-P388 leukemia and B16 melanoma effect.
- Specification
- Properties
- Price Product List
| Synonyms | 13-O-de(4-C-Acetyl-2,6-dideoxy-alpha-L-xylo-hexopyranosyl)-14,17-deepoxy-16-O-demethyl-16-O-(2,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-alpha-L-xylo-hexopyranosyl)-3-C-methyl-alpha-L-xylo-hexopyranosyl)-14,17-dihydroxy-13-O-methyltrixacarcin A; Trixacarcin A, 13-O-de(4-C-acetyl-2,6-dideoxy-alpha-L-xylo-hexopyranosyl)-14,17-deepoxy-16-O-demethyl-16-O-(2,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-alpha-L-xylo-hexopyranosyl)-3-C-methyl-alpha-L-xylo-hexopyranosyl)-14,17-dihydroxy-13-O-methyl- |
| Antibiotic Activity Spectrum | Gram-positive bacteria; neoplastics (Tumor) |
| Melting Point | 163-167°C |
| BBF-03868 | Honokiol | Inquiry |
| BBF-02800 | DB-2073 | Inquiry |
| BBF-00852 | Epothilon B | Inquiry |
| BBF-03819 | Spinosyn A | Inquiry |
| BBF-01732 | Mevastatin | Inquiry |
| BBF-05762 | Cyclosporin B | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
